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Abstract
Introduction: Inappropriate use of topical corticosteroids was found to cause different
dermatological complications. Despite its complex adverse effects, misuse of topical
corticosteroids has been a common practice throughout the world. The objective of
this study was to assess the prevalence of misuse of topical corticosteroids and its
associated factors in selected community pharmacies and cosmetics shops of Addis
Ababa.
Methods: A cross-sectional study design was conducted from February to April
in twelve community pharmacies and six cosmetics shops in Addis Ababa. A
convenience sampling method using semi-structured interviews was used to collect
topical corticosteroids use pattern and related adverse events. Descriptive statistics
were used to summarize the nature and frequency of cosmetic use while binary and
multinomial logistic regression was employed to test associated factors. Statistical
significance was set at p<0.05.
Result: From a total of 286 participants, more than two third obtained the topical
corticosteroids as over the counter. Among these, majority (59.8%) used for
beautification purpose. More than half of the users faced adverse drug events and the
most common affected site was face. Educational status was found to be associated
with OTC use of corticosteroids. Age, reading of label, frequency of application,
recommendation by friends and, mixing with other cosmetics and water have shown
statistically significant association with occurrence of adverse drug events.
Conclusion: Majority of the topical corticosteroids were obtained without prescription
for the purpose of beautification rather than treatment. A higher proportion of
cosmetic users reported to have experienced at least one adverse event. There needs
to consider safety concerns related to topical corticosteroids use in the city.
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1. Introduction
Topical corticosteroids (TCs) are group of drugs which has anti-inflammatory, immuno-
suppressive, anti-proliferative and vasoconstrictive effects [1]. Corticosteroids work by
binding to a specific receptor in the cellular cytoplasm andmodulating the transcription
of multiple genes that lead to the suppression of the production of inflammatory
substances such as; prostaglandins and leukotrienes aswell as by inhibiting the recruit-
ment of inflammatory cells into the skin [1, 2].
Since their introduction in the early 1950’s, TCs have become the cornerstone of
treatment mainly; for non-infective dermatologic disorders associated with inflam-
mation [3–5]. These disorders include a wide variety of dermatoses, such as atopic
dermatitis, eczema, contact dermatitis, psoriasis, seborrheic dermatitis, vitiligo, lichen
scleroses and intertrigo [6, 7].
Topical corticosteroids are the first-line therapy for the treatment of atopic der-
matitis according to various independently published international guidelines from
both dermatology and allergy groups worldwide [8, 10, 11]. Other studies have also
documented that these agents have a positive impact on the quality of life of patients
[12, 13]. Topical corticosteroids have been shown to be a safe treatment options both
in short-term daily use and long-term intermittent application [14].They are, specifi-
cally, recommended when patients have failed to respond to consistent eczema skin
care regimen, including the regular use of moisturizers (emollients), appropriate anti-
bacterial measures, and trying to eliminate any possible allergens that may be con-
tributing to the underlying conditions [8].
The potency of TCs has been assessed by measuring their vasoconstrictive effect on
the skin. Based on their potency, British National Formulary (BNF) divides the topical
corticosteroids into four groups, whereas American system divides them into seven
classes, where class I represents super potent or ultra-potent drugs and class VII the
least potent. Previous studies indicated significantly increased proportion of dermato-
logical visits related to a number of local and systemic adverse effects from misuse
of TC over the face, ranging from dermatitis and skin rashes to the development of
diabetes mellitus, hypertension and renal problems [15, 16]. The quick amelioration of
signs and symptoms of many facial dermatoses, the easy access of TC by the people
and their use as a cosmetics agent are the most important reasons for irrational use
of these groups of drugs [17, 18].
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Despite the occurrence of complex adverse effects, misuse of TCs has become a
common practice in the community. This study was conducted to assess the pattern
of misuse on TCs and factors associated to this practice in selected community phar-
macies and cosmetic shops of Addis Ababa.
2. Methods
2.1. Description of the study area and settings
Addis Ababa is the capital city of Ethiopia with a total population of 3,384,569 with
annual growth rate of 3.8% as reported on the 2007 census conducted by the central
statistical agency of Ethiopia [19]. According to the 2008 Ethiopian health and health
related indicators report, there were 378 pharmacies, 273 drug stores and 1 rural drug
vender in the city [20].
2.2. Study deign
A cross-sectional study design was conducted from February to April 2017 in selected
community pharmacies and cosmetics shops of Addis Ababa.
2.3. Source and study population
The source population included all TC users who visited community pharmacies and
cosmetics shops in Addis Ababa city administration whereas; the study population
included all customers who came to purchase TC with or without prescription during
the study period.
2.4. Sampling procedure and Sample size calculations
Because TCs were out of stock in the market during the stated period, convenience
sampling method was used to select Pharmacies and cosmetics shops. All customers
who came to buy TCs with or without prescription in the selected community phar-
macies were asked for consent and were made to fill out the questionnaires. Those
sent by other TC users were not asked since true information could not be obtained
from them. And in cosmetic shops, customers who came to purchase TCs which are
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not allowed (intermittent to super potent TCs) to be sold in cosmetic shops were asked
to fill out the questionnaire.
The minimum number of sample required for this study was determined by using
single population proportion formula considering the following assumptions:
𝑛 = (𝑍𝛼/2)
2𝑃 (1 − 𝑃 )
(𝐸)2
Where,
n= the required sample size
P=the prevalence of misuse of topical corticosteroids (p=0.79)
Z= Z score at 95% confidence interval=1.96
E = the margin of error=0.05
Accordingly, the sample size will be:
𝑛 = (1.96)
2 × 0.79(1 − 0.79)
(0.05)2
= 255
Assuming 10% non-response rate, the total sample size was 286.
2.5. Inclusion and Exclusion Criteria
Topical corticosteroid users in selected community pharmacy and cosmetics shop aged
18 or above were included in the study whilst, Consumers of other cosmetics products,
those aged below 18 and, those sent by other TC users were excluded from the study.
2.6. Data collection methods and quality assurance
Quantitative data collection method was employed and, a structured questionnaire
was used to determine the prevalence of TC misuse. The data collection questionnaire
was designed in English and transcribed to Amharic (the national working language of
the country). Training was given to data collectors and supervisors. Pre-test was done
two days before the start of actual data collection at one of the study areas. Based on
the findings from the pre- test, the questionnaire was revised and adopted.
2.7. Data entry and analysis
Descriptive statistics were used to summarize the nature and frequency of cosmetic
use. Bivariate logistic regression analyseswere applied to investigate the determinants
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of cosmetic use associated with adverse events. All explanatory variables associated
with the outcome variable in the bivariate analysis with p<0.20 were included in the
multivariate logistic regression model. SPSS version 20 for Windows was used for the
data entry and analysis. Statistical significance was set at p<0.05.
2.8. Operational Definitions
Misuse: The use of TCs out of the intended purpose (Treatment).
Topical corticosteroids: Any preparation that contains one or a combination of TCs
in the form of cream, ointment or lotion to be applied on the skin.
Cosmetic shops: Shops in which all kinds of cosmetics products are sold.
Cosmetics: TCs used for beautification purpose.
Community Pharmacies: drug retail outlets including drug stores and pharmacies
not owned by health facilities.
OTC use: use of TCs without appropriate prescription paper.
2.9. Ethical consideration
The Institutional Ethical Review Board of the School of Pharmacy, Addis Ababa Univer-
sity, gave permission to conduct the study. An official letter of cooperation was also
written from the Department of Pharmaceutics and Social Pharmacy and, the study
was conducted after securing permission from the selected community pharmacies
and cosmetics shops. Moreover, verbal consent was sought from every participant
after explaining about the nature of the study, objective, and expected duration of the
interview. Every subject was informed that participation in the study was fully volun-
tary. To assure anonymity, the name and address of the study participants were not
recorded on the questionnaires and all the information gathered was kept confidential.
3. Results
Findings from Selected cosmetic shops and Community Pharmacies
Among the 286 study participants approached in the study sites, 211(73.8%) were
female. One hundred thirty three (46.5%) of the participants were in the age group
18-28. More than half of TC users were single (54.5%). Majority of the participants had
a higher educational background (56.6%) (Table 1).
DOI 10.18502/sjms.v13i1.1689 Page 66













1-12 grade 124 43.4
Higher Education 162 56.6
Occupation
Student 31 10.8





Private Work 140 49.0
T 1: Socio-Demographic Characteristics of Topical Corticosteroid Users in Selected Community
Pharmacies and Cosmetics Shops of Addis Ababa, Ethiopia.
3.1. Extent of over the counter use of Topical corticosteroids
More than two third (68.5%) of the participants utilized TCs as over the counter (OTC)
and majority (60%) used the TCs for beautification purpose. Most of the participants
(44.1%) in the study area selected the TCs by consulting a health professional while
about one third of the participants selected TCs by asking a friend. Many of the par-
ticipants (73.4%) claimed to read information that is written on the container and
138 (48.3%) have reported that they read this information always when purchasing
cosmetics. Expiry date is themost commonly read information reported by 131 (45.8%)
subjects (Table 2).
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Less than1 month 94 32.9
1-6 month 81 28.3




Three and Greater than three times 18 6.3
Do you read information’s on the container
Yes 210 73.4
No 76 26.6
How do you use different cosmetics
Use each alone 210 73.4
Use different types by mixing 40 14.0
Use by mixing with water 36 12.6
T 2: Pattern of topical corticosteroids utilization in selected community pharmacies and cosmetics
shops in Addis Ababa, February 2017.
3.2. Adverse effects and actions taken
One hundred fifty (52.4%) of the participants faced any sort of adverse drug event
(ADE) and, the most commonly affected site was face (45%) followed by arm pit and
hair (17.1%). Twenty nine (19.3%) of those who faced the ADEs stopped using TCs for
some time and started back again when symptoms disappeared. Only 39 (13.6%) of
the study participants consulted health professionals.
Allergic reactions were the most common problems faced by the users, followed by
development of hair on face, sore on skin and face, Acne, discoloration on face and
skin, hair brittleness and breakage (Figure 1).
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Figure 1: Common ADR seen in TC users in selected pharmacies and cosmetic shops of Addis Ababa,
February 2017.
A-allergic reaction, B-development of hair on the face, C-sore on skin and face, D -acne,
E- discoloration on face and skin, F-hair brittleness and breakage, G-photosensitization, H-
feasibility of blood vessels, I-hyperpigmentation, J-skin thinning, K-stinging and darkening
of the arm pit, L-contact dermatitis, M-hypopigmentation
3.3. Factors associated with OTC use of TC
A logistic regression analysis was used to determine association between patients’
socio-demographic variables and OTC utilization of TCs. Significant association was
detected between OTC use and education. Participants who were in grades 1-12 (lower
level education) had two times used TCs as OTC than those who were in higher edu-
cation with AOR=2.67, 95%CI (1.49-4.79). However other socio-demographic variables
like age, gender, marital status, and occupation did not show a statistically significant
association (Table 3).
3.4. Factors associated with adverse effects of TC
A statically significant association was detected between adverse events and age.
Those participants in the age group 29-39 reported more adverse events than those
in the age group 18-28 and greater than 40. With AOR=2.45, 95% CI (1.11-5.39). A sig-
nificant association was also observed between frequency of application and adverse
events. Participants who applied a TC once and twice per day have a lesser prob-
ability of reporting ADEs as compared to those who applied more than twice with
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OTC Use
Variables Yes No COR AOR
Age
18-28 92 41 1.19[0.59-2.38] 1.35[0.62-
2.94]
29-39 72 32 1.18[0.58-2.45] 1.31[0.62-2.77]
Greater than 40 32 17 1.00 1.00
Gender
Female 145 66 1.03[0.58-1.82] 0.97[0.53-
1.75]
Male 51 24 1.00 1.00
Educational Status
1-12 98 267 2.46[1.44-4.20]* 2.67[1.49-
4.79]*
Higher Education 98 64 1.00 1.00
Marital Status
Single 100 56 0.63[0.38-1.05] 0.69[0.39-
1.24]
Married 96 34 1.00 1.00
Occupation
Student 23 8 1.27[0.52-3.07] 0.96[0.36-
2.54]
Governmental Employee 25 15 0.73[0.355-1.53] 0.79[0.37-
1.68]
Unemployed 11 6 0.81[0.28-2.34] 0.54[0.17-
1.65]
Non-governmental work 40 18 0.98[0.50-1.91] 1.07[0.53-2.16]
Private 97 43 1.00 1.00
T 3: Factors affecting OTC utilization of TCs in selected pharmacies and cosmetic shops of Addis Ababa,
February 2017.
AOR=0.16, 95% CI(0.44-0.69) and AOR= 0.15, 95%CI(0.39-0.63) respectively. The prob-
ability of ADE were three and five times higher for those who selected their TC by
asking their friends and who looks appearance and aroma respectively as compared to
those who used cost and affordability as a selection criteria (AOR= 3.32, 95% CI (1.64-
6.75)); (AOR=5.21, 95%CI (1.48-14.33)) respectively. Occurrence of ADEs was three
times higher for those who used their TC by mixing with other agents (AOR= 3.58,
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95% CI (2.2-7.83)). In addition, the occurance of ADE were also two times higher for
those TCS users who mixed their cosmetics with water (AOR=2.56, 95%CI (1.55-4.32)).
4. Discussion
The number of participants who reported to have experienced adverse cosmetic
events was higher as compared to figures documented in other parts of Ethiopia
[21, 22] and in other countries such as the Netherlands [23], UK [24], Nepal [25],
and Rio de Janeiro [26]. However, a higher figure had also been reported in a study
by Bilal et al. among residents of Jigjiga town in the same country [27]. This can
be explained, partly, by the little priority given to cosmetic use safety evaluations
and laboratory assessments in Ethiopia [28, 29]. In addition, most cosmetics outlets
lack proper channels of supply where most of these products are smuggled by non-
professional and uneducated sellers. This, in turn, may result in poor storage of the
products, product exposure to sunlight and inappropriate handling of products as
compared to cosmetics obtained from drug retail outlets [22].
This study also has shown that more number of female was found to use TCs than
male. Similar findings were obtained inside the country [30, 31]. This practice is again
reported in the rest of the world such as; South Africa, India, Pakistan and Iraq [32-
34]. Higher prevalence of TCs use among the females might be attributed to their
considerable interest to feel clean and attractive, increasing sexual stamina, feeling
good and sexually active as well as countering sexual risks as reported in some studies
[35, 36]. Other studies have also documented that females reported skin diseases,
emotional distress and associated contact dermatitis more often compared to males
[37–39].
Even though an earlier study indicated that there were OTC uses of TCs [31], the
higher figure in this studymay indicate the degree to howmuch the professionals were
not following the ethics and rules that govern the pharmaceutical sector. This problem
had been reflected in the significant number of TC users reporting an ADE. The fact
that those in grades 1-12 (lower level education) had a two times higher probability
of using TC as OTC indicates that there needs to do an educational campaign on this
group of users.
The frequency of use had also shown a statistically significant association with the
occurrence of ADE. Similar findings were reported inside the country where higher
frequency of use increased the occurrence of the ADE [27]. This study has clearly
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Adverse effects
Variables Yes No COR AOR
Age (Yrs.)
18-28 66 67 1.21[0.62-2.33] 1.46[0.65-3.27]
29-39 62 42 1.81[0.91-3.59] 2.45[1.11-5.39]*
>40 22 27 1.00 1.00
Sex
Male 43 32 1.00 1.00
Female 107 104 0.76[0.45-1.30] 0.71[0.38-1.32]
Educational Status
Grades 1-12 24 39 1.40[0.879-2.25] 0.93[0.50-1.72]
Higher Education 32 29 1.00 1.00
Marital Status
Single 76 80 0.71[0.45-1.14] 0.66[0.37-1.18]
Married 74 56 1.00 1.00
Occupation
Student 15 16 0.96[0.44-2.10] 0.59[0.22-1.54]
Governmental Employee 26 14 1.91[0.92-3.96] 1.99[0.84-4.70]
Unemployed 12 5 2.47[0.826-7.37] 1.76[0.45-6.78]
Non-governmental work 28 30 0.96[0.521-1.77] 0.75[0.36-1.56]
Private 69 71 1.00 1.00
Duration of application
Less than a month 50 44 1.28[0.74-2.23] 1.02[0.52-1.98]
1-6 months 48 33 1.65[0.92-2.945] 1.29[0.66-2.53]
Greater than 6 months 52 59 1.00 1.00
Frequency of application
Once 97 97 0.28[0.91-0.89]* 0.16[0.44-0.69]*
Twice 39 35 0.31[0.09-1.05] 0.15[0.39-0.63]*
3 or more times 14 4 1.00 1.00
Selection of TCS
Recommended by friends 51 27 3.10 [1.36-6.98.]* 3.32[1.64-6.75]*
Looking appearance and
aroma
15 5 4.92 [1.46-16.53]* 5.21[1.48-14.33]*
Recommended by health
professionals
59 60 1.61 [0.75-3.43] 1.34[0.82-3.11]
Recommended by shop
owners
11 21 0.861 [0.32-2.30] 1.12[0.45-2.2]
Low cost 14 23 1.00 1.00
Use of different
cosmetics
Using TCS without mixing
with other cosmetics
99 116 1.00 1.00
Using TCS by mixing with
other cosmetics
30 9 3.90[1.77-8.61]* 3.58[2.2-7.83]
Using TCS by mixing with
water
21 11 2.23 [1.02-4.866] 2.56 [1.55-4.32]
*Statistically significant association at 95% CI
T 4: Factors affecting adverse effects of TC in selected pharmacies and cosmetic shops of Addis Ababa,
February 2017.
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shown that the participants who selected their TCs by friends as well as by looking
appearance and aroma were at a higher risk to develop an ADE. This underscores the
importance of consulting health professionals while selecting the TCs for use. Likewise,
a three and two times increase in ADE was reported by TC users who applied through
mixing it with other cosmetics and water. This could be explained by presence of
interaction between cosmetic products or a synergistic effect of the products to each
other. similar studies also reported that mixing of cosmetics with other substances like
water and saliva increase the ADE [21, 27].
This study has tried to catch those users who visited both community pharmacies
and cosmetics shops for obtaining their TC. However, some of the adverse events
reported by the study participants might have not, necessarily, been caused by the
cosmetic product they used. There needs further investigation for causality assess-
ment which was beyond the scope of this study.
5. Conclusion
The result of this study has revealed that most TCs were being utilized without a
prescription. Besides, many participants have reported to purchase TCs for beautifi-
cation purpose rather than treatment. Significant number of users had experienced
adverse events in which frequency of application, the way of selection and mixing the
TC with other cosmetics and substances were important predictors for such events.
There needs a due consideration on cosmetic use-related safety concerns through
awareness creation programs and promoting the concept of cosmetovigilance among
cosmetic sellers, users, and other stakeholders.
6. List of Abbreviations
ADR: Adverse drug reaction
AOR: Adjusted odds ratio
BNF: British National Formulary
COR: Crudes odds ratio
CSA: Central Statistical Agency of Ethiopia
FMHACA: Food Medicine and Healthcare administration and control authority
OTC: Over the counter
SPSS: Statistical package for the social science program
TC: Topical corticosteroids
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